Search

everythinglearnresearchcommunity

for

Search:↓

Scalp cooling therapy helped over 80% of women keep at least half their hair during chemotherapy.

Green tea extract helps prevent cell death and supports cell survival in hair cells exposed to a chemotherapy drug.

Eliminating senescent cells can prevent and reverse chemotherapy-induced peripheral neuropathy.

Taxane chemotherapy can cause skin, hair, and nail side effects, which are often under-reported and can affect patient quality of life.

Paclitaxel and nab-paclitaxel can be safe and effective for advanced gastric cancer patients on hemodialysis.

Combining gemcitabine with paclitaxel is more effective than with pemetrexed for advanced lung cancer.

The Li-Pa/Ca and Do/Ca chemotherapy regimens for serous ovarian cancer showed better short-term and long-term results than the Pa/Ca regimen.

The combination therapy is effective and well-tolerated for treating esophageal cancer.

The new drug carriers show promise for better targeting and treating ovarian cancer.

The treatment showed high response rates and was well-tolerated, potentially extending patient survival.

Chemotherapy can cause skin issues and hair loss, and this guide explains how to manage them.

Eribulin-based chemotherapy is more effective and has fewer side effects for advanced triple-negative breast cancer.

About half the patients treated with capecitabine and docetaxel developed severe hand-foot syndrome.

Anti-cancer treatments can cause reversible hair loss, skin sensitivity, pigmentation changes, nail damage, and skin reactions, with a need for more research on managing these side effects.

In 2002, various skin reactions were reported due to different drugs, including allergies, hair loss, skin lesions, and other skin conditions.

A woman regrew her hair after receiving injections of special cell-derived vesicles.

Cooling the scalp may prevent hair loss from chemotherapy, hair often grows back after treatment, and nail issues usually improve after stopping the drug.

The combination of high-dose toremifene and capecitabine was effective for advanced recurrent breast cancer.

The document reviews 20 U.S. patents from July and August 2004 about new drug forms, cancer treatments, aroma chemicals, statin drugs, and various chemical production methods.

IL-1 alpha stops hair follicle growth and hair production.

Human dental pulp stem cell-conditioned medium, especially from hypoxic conditions, may help treat chemotherapy-induced hair loss and does not increase cancer risk.

Increasing ABC transporters in hair follicles may prevent chemotherapy-induced hair loss.

Semecarpus anacardium leaf extracts may offer safe, effective cancer treatment alternatives.

Patients with metastatic breast cancer treated with epirubicin and docetaxel had a good response and maintained their quality of life.

Scalp cooling is the only FDA-approved method to prevent hair loss from chemotherapy, but other treatments like minoxidil and PRP are being tested.

Ayurveda, using herbs like ginger, garlic, and turmeric, can reduce chemo-radiotherapy side effects in cancer patients.

The document concludes that systemic therapy is becoming more important in treating head and neck cancer, with new treatments showing promise.

The new chemotherapy combination of WP 631 and Epothilone B shows enhanced effectiveness against ovarian cancer but requires more research on its safety.

Chemotherapy causes hair loss by damaging hair follicles and stem cells, with more research needed for prevention and treatment.

Chemotherapy caused a woman's permanent hair loss and early menopause.